Ain Holdings Inc. · TSE:9627
Ain — Q2 FY4/23 Earnings Presentation
26 slides from Ain's earnings presentation, Dec 8, 2022
Slide 1: FY4/23 2Q IR Presentation
FY4/23 2Q IR PRESENTATION December 2022
Slide 2: Results Overview
Results Overview © 2022 AIN HOLDINGS INC. All Rights Reserved. 1
Slide 3: Consolidated P/L
Consolidated P/L Net sales increased 11.9% YoY and declined 0.9% against the plan due to new store openings and contribution of existing stores, despite the impact of the COVID-19. Ordinary profit increased 18.9% YoY and declined 16.6% against the plan due to increase of sales. FY4/22 2Q FY4/23 2Q F
Slide 4: Dispensing Pharmacy Business (Consolidated)
Dispensing Pharmacy Business (Consolidated) Net sales increased 11.9% YoY and declined 0.9% against the plan due to new store openings including M&A and contribution of stores opened previous year. Segment profit increased 2.6% YoY and declined 17.4% against the plan. FY4/22 2Q FY4/23 2Q FY4/23 2Q Y
Slide 5: Cosmetic and Drug Store Business (Consolidated)
Cosmetic and Drug Store Business (Consolidated) Net sales up 24.3% YoY and 0.1% against the plan due to the recovery of existing stores and contribution of stores opened in previous year despite the impact of the COVID-19. Segment profit was ¥349 million, ¥403 million above the plan. FY4/22 2Q FY4/2
Slide 6: Consolidated B/S
Consolidated B/S Net cash became ¥32,608 million and shareholdersʼ equity ratio became 52.3%. We are maintaining a sound financial structure even under the ongoing COVID-19 situation. End-FY4/22 (¥ million) End-FY4/23 2Q (¥ million) Assets Liabilities Assets Liabilities Current assets Current Curren
Slide 7: Assets
Assets The balance of total assets increased ¥18,680 million from the end of the previous fiscal year due to decrease of cash on hand and in banks and increase of inventories and goodwill. (¥ million) End-FY4/22 2Q End-FY4/22 End-FY4/23 2Q Change Cash on hand and in banks 58,692 59,729 46,723 (13,00
Slide 8: Liabilities and Net Assets
Liabilities and Net Assets Accounts payable increased ¥9,963 million due to new store openings including M&A. Short- term and long-term debt increased ¥5,356 million. (¥ million) End-FY4/22 2Q End-FY4/22 End-FY4/23 2Q Change Accounts payable 51,465 50,756 60,719 +9,963 Short-term debt 3,051 2,643 3,
Slide 9: Consolidated C/F
Consolidated C/F Cash and cash equivalents at the end of the period decreased ¥14,918 million from the previous year due to decrease of net cash used in investing activities by ¥10,356 million resulting from a large M&A transaction, but the company maintained ample cash. (¥ million) FY4/22 2Q FY4/23
Slide 10: Business Value Analysis
Business Value Analysis FY4/22 2Q FY4/22 FY4/23 2Q Change Shareholdersʼ equity ratio (%) 55.0 56.0 52.3 (2.7) Market value equity ratio (%) 112.3 96.6 95.0 (17.3) PER (times) 35.43 28.99 28.86 (6.57) EPS (¥) 94.68 201.47 108.30 +13.62 PBR (times) 2.05 1.74 1.83 (0.22) BPS (¥) 3,285.58 3,385.51 3,438
Slide 11: FY4/23 Plan (Consolidated)
FY4/23 Plan (Consolidated) The group forecasts net sales for the fiscal year ending April 30, 2023 of ¥363,000 million, increase 14.8% YoY and ordinary profit of ¥20,500 million, increase 27.8% YoY. FY4/21 FY4/22 FY4/23 YoY YoY （¥ million） results results plan change change(%) Net sales 297,305 316,
Slide 12: Review
Review © 2022 AIN HOLDINGS INC. All Rights Reserved. 11
Slide 13: Daily new COVID-19 cases across Japan
Daily new COVID-19 cases across Japan As of December 7, the number of domestic cases of the COVID-19 infection and deaths was 25,554,733 and 50,819, respectively. （people） 300,000 7th wave Aug.2 263,535 250,000 Declaration of the Declaration of the Pre-emergency state of emergency state of emergency
Slide 14: Review (YoY)
Review (YoY) Ordinary profit increased ¥1.1 billion due to increase of net sales in both dispensing pharmacy and cosmetic and drug store businesses. Net sales +¥18.2 billion Ordinary profit +¥1.1 billion ¥171.2 billion +11.9% ¥153.0 billion +18.9% ¥7.2 billion ■Dispensing ¥6.1 billion ■Dispensing Ph
Slide 15: Review (vs Plan)
Review (vs Plan) Net sales decrease ¥1.6 billion and ordinary profit ¥1.5 billion against the plan due to below-plan prescription volume. Net sales ¥(1.6) billion Ordinary profit ¥(1.5) billion ¥172.8 billion ¥171.2 billion (0.9)% ¥8.7 billion ¥7.2 billion (16.6)% ■Dispensing ■Dispensing Pharmacy Ph
Slide 16: Strategy
Strategy © 2022 AIN HOLDINGS INC. All Rights Reserved. 15
Slide 17: Strategy
Strategy Expansion of top-line ■Dispensing Pharmacy Plan to open 160 pharmacies（Organic 48, M&A 112） ■Cosmetic and Drug Store Plan to open 10 stores Recruiting and training of human resources ■Planning to hire 500 newly graduated pharmacists（hired 660 new pharmacists in FY4/22） ■Make the Field Manag
Slide 18: Expansion of top-line: Ordinary profit
Expansion of top-line ■Dispensing Pharmacy Plan to open 160 pharmacies（Organic 48, M&A 112） ■Cosmetic and Drug Store Plan to open 10 stores ■ Top-line ¥316.2 billion +14.8% ¥363.0 billion ¥171.2 billion ■Dispensing Pharmacy ¥283.1 billion ¥326.0 billion ¥153.2 billion ■Cosmetic and Drug store ¥20.5
Slide 19: Expansion of top-line
Expansion of top-line ■Dispensing Pharmacy Plan to open 160 pharmacies（Organic 48, M&A 112） ■Cosmetic and Drug Store Plan to open 10 stores FY4/23 2Q Results FY4/23 Plan 109 1,287 1,332 17 Dispensing Dispensing Pharmacies 1,209 Pharmacies 1,249 Cosmetic and 78 Cosmetic and 83 166 Drug stores Drug st
Slide 20: Expansion of top-line: Opening
Expansion of top-line ■Dispensing Pharmacy Plan to open 160 pharmacies（Organic 48, M&A 112） ■Cosmetic and Drug Store Plan to open 10 stores ■ Plan FY4/23 2Q FY4/23 Plan Results Plan Dispensing Pharmacy 121 124 160 Organic 13 12 48 Opening 108 112 112 M&A 10 Cosmetic and drug store 5 4 170 Total 126
Slide 21: Recruiting and training of human resources
Recruiting and training of human resources ■Planning to hire 500 newly graduated pharmacists（hired 660 new pharmacists in FY4/22） ■Make the Field Manager system more established ■Training of human resources In April 2022, new 660 pharmacists has joined our group. We aim to hire 500 pharmacists, in f
Slide 22: Reinforcing the Group's business base
Reinforcing the Groupʼs business base ■Improving the customer services by promoting DX, such as official apps ■Promoting Sustainability Management We have conducted our corporate activities with common sense and ethics in order to realize our group statement of “the health and happiness of our custo
Slide 23: Reinforcing the Group's business base
Reinforcing the Groupʼs business base ■Improving the customer services by promoting DX, such as official apps ■Promoting Sustainability Management In order to realize a sustainable society, it is important to work not only within the Group but also throughout the entire supply chain. we are promotin
Slide 24: Turnaround and expansion of AINZ&TULPE
Turnaround and expansion of AINZ&TULPE ■Opening stores in prime locations and optimizing costs AINZ & TULPE Already opened in FY4/23 4 stores STELLAR PLACE Sapporo (Opened in October 2022) KOBE MOTOMACHI (Opened in June 2022) MOSAICMALL Kohoku FUTAKO TAMAGAWA RISE (Opened in May 2022) (Opened in Oct
Slide 25: FY4/23 Plan (Consolidated)
FY4/23 Plan (Consolidated) The group forecasts net sales for the fiscal year ending April 30, 2023 of ¥363,000 million, increase 14.8% YoY and ordinary profit of ¥20,500 million, increase 27.8% YoY. FY4/21 FY4/22 FY4/23 YoY YoY （¥ million） results results plan change change(%) Net sales 297,305 316,
Slide 26: AIN HOLDINGS INC. Corporate Planning Division
Inquiries related to this presentation should be addressed to AIN HOLDINGS INC. Corporate Planning Division TEL(81)11-814-0010 FAX(81)11-814-5550 https://www.ainj.co.jp/ This document may not be reproduced or distributed to any third party without prior approval of AIN HOLDINGS INC. This document ha